Amneal Pharmaceuticals, Inc. (FRA:2DT)

Amneal Pharmaceuticals Revenue

Amneal Pharmaceuticals had revenue of $784.51M USD in the quarter ending September 30, 2025, with 11.68% growth. This brings the company's revenue in the last twelve months to $2.93B, up 9.50% year-over-year. In the year 2024, Amneal Pharmaceuticals had annual revenue of $2.79B with 16.73% growth.

• Revenue (ttm): $2.93B
• Revenue Growth: +9.50%
• P/S Ratio: 1.33
• Revenue / Employee: $353.61K
• Employees: 8,300
• Market Cap: 3.33B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.79B	400.35M	16.73%
Dec 31, 2023	2.39B	181.30M	8.20%
Dec 31, 2022	2.21B	118.64M	5.67%
Dec 31, 2021	2.09B	101.15M	5.08%
Dec 31, 2020	1.99B	366.15M	22.51%
Dec 31, 2019	1.63B	-36.62M	-2.20%
Dec 31, 2018	1.66B	629.34M	60.88%
Dec 31, 2017	1.03B	15.43M	1.52%
Dec 31, 2016	1.02B	-	-